Stryker Corporation Stock

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
325.4 USD -0.62% Intraday chart for Stryker Corporation -4.86% +8.67%
Sales 2024 * 22.18B Sales 2025 * 23.84B Capitalization 124B
Net income 2024 * 3.88B Net income 2025 * 4.4B EV / Sales 2024 * 5.93 x
Net Debt 2024 * 7.75B Net Debt 2025 * 5.35B EV / Sales 2025 * 5.42 x
P/E ratio 2024 *
32.6 x
P/E ratio 2025 *
28.5 x
Employees 52,000
Yield 2024 *
0.98%
Yield 2025 *
1.06%
Free-Float 94.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.62%
1 week-4.86%
Current month-9.06%
1 month-8.82%
3 months+3.29%
6 months+21.24%
Current year+8.67%
More quotes
1 week
324.68
Extreme 324.68
346.33
1 month
324.68
Extreme 324.68
359.50
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
75.78
Extreme 75.78
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 11-04-24
Director of Finance/CFO 62 02-12-31
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 80 73-12-31
Director/Board Member 65 18-05-01
Director/Board Member 89 77-01-31
More insiders
Date Price Change Volume
24-04-19 325.4 -0.62% 1,884,151
24-04-18 327.4 -2.55% 2,143,604
24-04-17 336 -0.48% 1,066,062
24-04-16 337.7 -0.43% 1,239,358
24-04-15 339.1 -0.85% 1,087,797

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
325.4 USD
Average target price
365.7 USD
Spread / Average Target
+12.37%
Consensus